Previous work had shown that initiation of ART during a 4 month time window after HIV-1 infection was associated with an enhanced likelihood of CD4+ T lymphocytes counts and CD4+ T lymphocytes being preserved with early therapy independent of seroconversion status [56,57]. This evidence concerns the gene CD4 and HIV-1 infection.